Antihyperlipidemic properties of novel N-(benzoylphenyl)-5-substituted-1H- indole-2-carboxamides in Triton WR-1339-induced hyperlipidemic rats

Molecules

Volumn 16, Issue 10, 2011, Pages 8292-8304

  Al Hiari, Yusuf ^a   Shattat, Ghassan ^b   Al Qirim, Tariq ^b   El Huneidi, Waseem ^b   Sheikha, Ghassan Abu ^b   Hikmat, Suhair ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b AL ZAYTOONAH UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Hypolipidemic activity; N (benzoylphenyl) 5 chloro 1H indole 2 carboxamide; N (benzoylphenyl) 5 methoxy 1H indole 2 carboxamide; Triton WR 1339 induced hyperlipidemic rats

Indexed keywords

ANTILIPEMIC AGENT; BEZAFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDOLE DERIVATIVE; MACROGOL DERIVATIVE; N (BENZOYLPHENYL) 5 CHLORO 1H INDOLE 2 CARBOXAMIDE; N (BENZOYLPHENYL) 5 METHOXY 1H INDOLE 2 CARBOXAMIDE; N-(BENZOYLPHENYL)-5-CHLORO-1H-INDOLE-2-CARBOXAMIDE; N-(BENZOYLPHENYL)-5-METHOXY-1H-INDOLE-2-CARBOXAMIDE; TRIACYLGLYCEROL; TYLOXAPOL;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; HYPERLIPIDEMIA; MALE; RAT; SYNTHESIS; WISTAR RAT;

ANIMALS; BEZAFIBRATE; CHOLESTEROL, HDL; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; INDOLES; MALE; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 80054923585     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16108292     Document Type: Article

References (32)

1. Epstein, F. M. The hepatorenal syndrome-newer perspectives. N. Engl. J. Med. 1992, 327, 1774-1778.
2. Raasch, R. H. Hyperlipidemias in Applied Therapeutics. In The Clinical Use of Drugs, Young, L. Y., Koda-Kimble, M. A., Eds.; Edwards Brothers: Ann Arbor, MI, USA, 1988; pp. 1743-1745.
3. Frishman, W. H. Biologic markers as predictors of cardiovascular disease. Am. J. Med. 1998, 104, 18S-27S. (Pubitemid 28343009)
4. Goldstein, J. L.; Hazzard, W. R.; Schrott, H. G.; Bierman, E. L.; Motulsky, A. G. Hyperlipidemia in coronary heart disease I. Lipid levels in 500 survivors of myocardial infarction. J. Clin. Invest. 1973, 52, 1533-1543.
5. Martin, M. J.; Hulley, S. B.; Browner, W. S.; Kuller, L. H.; Wentworth, D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361, 662 men. Lancet 1986, 2, 933-936. (Pubitemid 17197838)
6. West, K. M.; Ahuja, M. S.; Bennet, P. H. The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983, 6, 361-369. (Pubitemid 13078717)
7. Kellner, A.; Correll, J. W.; Ladd, A. T.; Sustained hyperlipemia induced in rabbits by means of intravenously injected surface-active agents. J. Exp. Med. 1951, 93, 373-384.
8. Schotz, M. C.; Scanu, A.; Page, I. H. Effect of Triton on lipoprotein lipase of rat plasma. Am. J. Physiol. 1957, 188, 399-402.
9. Kalopissis, A. D.; Griglio, S.; Malewiak, M. I.; Rosen, R. Effect of a high-fat diet on rat very low density lipoprotein secretion. Biochim. Biophys. Acta 1980, 620, 111-119. (Pubitemid 11254885)
10. Paoletti, R. Comparative studies on hypocholesterolemic agents. Am. J. Clin. Nutr. 1962, 10, 277-284.
11. Da Rocha, J. T.; Sperança, A.; Nogueira, C. W.; Zeni, G. Hypolipidaemic activity of orally administered diphenyl diselenide in triton WR-1339-induced hyperlipidaemia in mice. J. Pharm. Pharmacol. 2009, 61, 1673-1679.
12. Frick, M. H.; Elo, O.; Haapa, K.; Heinonen, O. P.; Heinsalmi, P.; Helo, P.; Huttunen, J. K.; Kaitaniemi, P.; Koskinen, P.; Manninen, V.; Mäenpää, H.; Mälkänen, M.; Mänttäri, M.; Norola, S.; Pasternack, A.; Pikkarainen, J.; Romo, M.; Sjäblom, T.; Nikkilä, E. A. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med. 1987, 317, 1237-1245. (Pubitemid 17147964)
13. Schoonjans, K.; Staels, B.; Auwerx, J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 1996, 37, 907-925. (Pubitemid 26182326)
14. Bosies, E.; Heerdt, R.; Kuknle, H. F.; Schmidt, F. H.; Stach, H. Hypoglycemically and Hypolipidemically Active Derivatives of Phenylalkane Carboxylic Acids. U. S. Patent 4238506 A, 19801209, 1980;
15. CAN 95:150207, 1980.
16. Dasseux, J. L. H.; Oniciu, C. D. Ketone Compounds and Compositions for Cholesterol Management and Related Uses. WO 2002030860 A2 20020418, 2002; U. S. Patent 136:325529, 2002.
17. Kopin, A. S.; Carey, M.; Wang, D. Methods of Altering Intestinal Motility and Absorption of Hydrophobic Compounds through the Use of Agonists and/or Antagonists of the Cholecystokinin-1 Receptor. U. S. Patent Appl. Publ. US 20060177438 A1, 20060810, 2006, Appllication number US 2005-53553, 2005; CAN 145:224869, 2005.
18. Sher P. M.; Ellsworth B. A. Triglyceride and Triglyceride-Like Prodrugs of Glycogen Phosphorylase Inhibiting Compounds. U. S. Patent Appl. Publ. US 20040142938 A1, 20040722, 2004; US 7098235 B2, 2006; U. S. CAN 141:140474, 2004.
19. Shahwan, M.; Shattat, G.; Al-Qirim, T.; Abu Sheikha, G.; Al-Hiari, Y.; El-Huneidi, W.; Jarab, A.; AL-Najdawi, M. Synthesis and pharmacological evaluation of novel substitutedand unsubstituted N-(benzoylphenyl)-1H-indole-2- carboxamides as potent antihypertriglyceridemic agents. Z. Naturforsch. 2010, 65 c, 309-316.
20. Shattat, G.; Al-Qirim, R.; Al-Hiari, Y.; Abu Sheikha, G.; Al-Qirim, T.; El-Huneidi, W.; Shahwan, M. Synthesis and Anti-Hyperlipidemic Evaluation of N-(Benzoylphenyl)-5-fluoro-1H-indole-2-carboxamide Derivatives in Triton WR-1339-Induced Hyperlipidemic Rats. Molecules 2010, 15, 5840-5849.
21. Al-Qirim, T.; Shahwan, M.; Shattat, G.; Al-Hiari, Y.; Abu Sheikha, G.; Zaidi, S. Pharmacological evaluation of novel indole-2-carboxamides as potent lipid-lowering agents in Triton-WR1339-induced hyperlipidemic rats. Z. Naturforsch. 2009, 64 c, 619-625.
22. Pérez, C.; Canal, J. R.; Campello, J. E.; Adelaida, R.; Torres, M. D. Hypotriglyceridaemic activity of Ficus carica leaves in experimental hypertriglyceridaemic rats. Phytother. Res. 1999, 13, 188-191. (Pubitemid 29229443)
23. Khanna, A. K.; Chauder, R.; Chandan, S.; Srivastava, A. K.; Kapoor, N. K. Hypolipidemic activity of Achyranthus aspera linn in normal and triton induces htperlipemic rats. Indian J. Exp. Biol. 1992, 30, 128-130.
24. Khanna, A. K.; Rizvi, F.; Chander, R. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J. Ethnopharmacol. 2002, 82, 19-22.
25. Schurr, P. E.; Schultz, J. R.; Parkinson, T. M. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids 1972, 7, 69-74.
26. Otway, S.; Robinson, D. S. The effect of the nonionic detergent (Triton) on the removal of triglyceride fatty acids from the blood of the rats. J. Physiol. 1967, 190, 309-319.
27. Malloy, M. J.; Kan, J. P. Medical management of hyperlipidemic states. Ad. Int. Med 1994, 39, 603-631.
28. Anila, L.; Vijayalakshmi, N. R. Flavonoids from Emblica officinalis and Mangifera indicaeffectiveness for dyslipidemia. J. Ethnopharmacol. 2002, 79, 81-87. (Pubitemid 34017244)
29. Vijaya, C.; Ramanathan, M.; Suresh, B. Lipid lowering activity of ethanolic extract of leaves of Aegle marmelos (Linn.) in hyperlipidaemic models of Wistar albino Rats. Indian J. Exp. Biol. 2009, 47, 182-185.
30. Nagao, K.; Sakono, M.; Nakayama, M.; Hirakawa, T.; Imaizumi, K. Effect of gemfibrozil on triacylglycerol synthesis and secretion by liver and lipoprotein lipase activity in adipose tissue of rats. Comp. Biochem. Phys. B 1999, 124, 289-294. (Pubitemid 29502594)
31. Nakajima, T.; Tanaka, N.; Kanbe, H.; Hara, A.; Kamijo, Y.; Zhang, X.; Gonzalez, F. J.; Aoyama, T.; Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: A novel peroxisome proliferator-activated receptor alpha-independent mechanism. Mol. Pharmacol. 2009, 75, 782-792.
32. Mori, Y.; Tokutate, Y.; Oana, F.; Matsuzawa, A.; Akahane, S.; Tajima, N. Bezafibrate-induced changes over time in the expression of uncoupling protein (UCP) mRNA in the tissues: A study in spontaneously type 2 diabetic rats with visceral obesity. J. Atheroscler. Thromb. 2004, 11, 224-231.